It signals the start of the technical process known as the generic assessment design (GDA), which makes a detailed examination of all aspects surrounding nuclear reactors.
Mutual, however, argues that federal law preempts this type of claim, because the FDA had already approved its drug and federal law also requires a generic drug to have the same design as the brand-name medication ( here is the petition).
Mutual and the Obama administration want that protection extended to the design of the drug, since the generic is an exact copy of the brand-name drug that has already been approved by the federal government.
The pending Bartlett case will determine whether Mensing applies to design-defect claims and whether it requires a finding that such claims against generic drug manufacturers are similarly preempted.
Virtual tschotskes beckon: Instead of selling generic virtual "gifts" like Facebook does, later this autumn Bianchini aims to give users the ability to design their own virtual presents and sell those (vampire love-bites, anyone?).